Ingrid Michon - Concepedia

Author

Ingrid Michon

Leiden University ORCID

Also Known As

I. Michon, I.N. Michon, Ingrid Michon, Ingrid N Michon, Ingrid N. Michon

Publications

439

Citations

H-Index

Concepts

All Affiliations

Leiden University Analytical Biosciences (China)

About

Ingrid Michon is an author at Leiden University specializing in medicine, molecular physiology, and vascular biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	220
2	Cell Biology	2	2	53
3	Health Sciences	1	1	22
4	Biochemistry	1	1	109
5	Biomolecular Engineering	1	1	31

Ingrid Michon

Publications

396

Citations

H-Index

Page 1

	Year	Citations
Uptake and Processing of Modified Bacteriophage M13 in Mice: Implications for Phage Display Tom J.M. Molenaar, Ingrid Michon, Sonja Haas, Virology BiochemistryPathogenesisBacteriophageModified Bacteriophage M13Microbiology	2002	109
P-selectin as a candidate target in atherosclerosis Tom J.M. Molenaar, Jaap Twisk, Sonja Haas, Biochemical Pharmacology InflammationVascular DiseaseCardiovascular DiseaseMedicineVascular Biology	2003	58
Specific inhibition of P-selectin–mediated cell adhesion by phage display–derived peptide antagonists Tom J.M. Molenaar, Chantal C.M. Appeldoorn, Sonja Haas, Blood	2002	55
IL-15 aggravates atherosclerotic lesion development in LDL receptor deficient mice Thomas van Es, Gijs H.M. van Puijvelde, Ingrid Michon, Vaccine	2010	41
Targeting of peptides to restenotic vascular smooth muscle cells using phage display in vitro and in vivo Ingrid Michon, Arnaud D. Hauer, Jan H. von der Thüsen, Biochimica et Biophysica Acta (BBA) - Molecular Cell Research Molecular PhysiologyMedicinePeptide EngineeringPeptide LibraryEndothelial Dysfunction	2002	31
Microarray analysis indicates an important role for FABP5 and putative novel FABPs on a Western-type diet Menno Hoekstra, Miranda Stitzinger, Eva J.A. van Wanrooij, Journal of Lipid Research	2006	27
A Physiologically-Based Pharmacokinetic (PBPK) Model Network for the Prediction of CYP1A2 and CYP2C19 Drug–Drug–Gene Interactions with Fluvoxamine, Omeprazole, S-mephenytoin, Moclobemide, Tizanidine, Mexiletine, Ethinylestradiol, and Caffeine Tobias Kanacher, Andreas Lindauer, Enrica Mezzalana, Pharmaceutics	2020	25
The effect of TGF-β receptor binding peptides on smooth muscle cells Ingrid Michon, Louis C. Penning, Tom J.M. Molenaar, Biochemical and Biophysical Research Communications Muscle PhysiologyMolecular PhysiologySignal TransductionTgf-β ReceptorSkeletal Muscle	2002	22
Pharmacokinetics and safety of fidaxomicin in patients with inflammatory bowel disease and Clostridium difficile infection: an open-label Phase IIIb/IV study (PROFILE) Christoph Högenauer, Yashwant R. Mahida, Andreas Stallmach, Journal of Antimicrobial Chemotherapy	2018	17
Tiered approach to evaluate the <scp>CYP3A</scp> victim and perpetrator drug–drug interaction potential for vonoprazan using <scp>PBPK</scp> modeling and clinical data to inform labeling Darcy J. Mulford, Diane Ramsden, Liming Zhang, CPT Pharmacometrics & Systems Pharmacology	2023	11

Page 1